Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US

Ultrasonography (US) is the most commonly used liver imaging modality worldwide. Unfortunately, it has limited sensitivity in the detection of small tumor nodules. Moreover, US findings are often nonspecific, as appearances of benign and malignant liver lesions overlap. The introduction of microbubb...

Full description

Saved in:
Bibliographic Details
Published in:European radiology 2007-12, Vol.17 Suppl 6, p.F73-F79
Main Authors: Lencioni, Riccardo, Della Pina, Clotilde, Crocetti, Laura, Bozzi, Elena, Cioni, Dania
Format: Article
Language:English
Subjects:
Carcinoma, Hepatocellular - diagnostic imaging
Carcinoma, Hepatocellular - therapy
Contrast Media
Humans
Incidental Findings
Liver Cirrhosis - complications
Liver Neoplasms - diagnostic imaging
Liver Neoplasms - secondary
Liver Neoplasms - therapy
Practice Guidelines as Topic
Sensitivity and Specificity
Ultrasonography, Interventional
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ultrasonography (US) is the most commonly used liver imaging modality worldwide. Unfortunately, it has limited sensitivity in the detection of small tumor nodules. Moreover, US findings are often nonspecific, as appearances of benign and malignant liver lesions overlap. The introduction of microbubble contrast agents and the development of contrast-specific techniques have opened new prospects in liver US. The advent of second-generation agents that enable continuous real-time contrast-enhanced imaging has been instrumental in improving the acceptance and reproducibility of the examination. With the publication of guidelines for the use of contrast agents in liver US by the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB), contrast-enhanced US has entered clinical practice. The guidelines define the indications and recommendations for the use of contrast agents in focal liver lesion detection, characterization, and posttreatment follow-up. Recently, the clinical value of contrast US as a reliable alternative to CT or MR imaging in characterizing hepatocellular carcinoma in cirrhosis has been endorsed by the practice guideline document issued by the American Association for the Study of Liver Diseases and the 2005 Monothematic Conference on Hepatocellular Carcinoma of the European Association for the Study of the Liver. In this article, the current role of contrast US in the diagnostic management of focal liver lesions is discussed with regard to the following clinical scenarios: (1) characterization of incidental findings; (2) diagnosis of hepatocellular carcinoma in patients with cirrhosis; and (3) identification of hepatic metastases in oncology patients; (4) guidance and monitoring of tumor ablation procedures.
ISSN:0938-7994